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Obesity is a well-known major risk factor of cardiovascular disease and is associated with various comorbidities. The impact
of obesity on pulmonary function remains unclear. Reductions in chest wall compliance and respiratory muscle strength due
to a high percent body fat and localized fat distribution contributes to impaired pulmonary function and the occurrence of
adverse respiratory symptoms. Dietary modiﬁcations and pharmaceutical agents are not eﬀective in the long-term treatment of
obesity. Treatment of morbidly obese patients using bariatric surgery has increased each year, especially after the introduction
of video laparoscopic techniques. Eﬀective weight loss after bariatric surgery may improve cardiovascular disease risk factors,
includingdiabetes,hypertension,dyslipidemia,atherosclerosis,inﬂammation,chronickidneydisease,obstructivesleepapnea,and
obesity hypoventilation syndrome. Bariatric surgery has also been associated with signiﬁcantly improved respiratory symptoms
and pulmonary function. We currently present a review of principal studies that evaluated the eﬀects of obesity on pulmonary
function and the identiﬁcation of anthropometric factors of obesity that correspond to the reversal of respiratory symptoms and
impaired pulmonary function after bariatric surgery.
1.Introduction
The prevalence of obesity has increased worldwide in both
developing and developed countries [1]. The majority of
long-term epidemiologic studies have shown that obesity is
associated with increased comorbidities such as cardiovas-
cular disease, metabolic disorders, diabetes, cancer, chronic
kidney disease (CKD), and immunologic dysfunction [2–
4]. Obesity has also been shown to negatively impact the
respiratory system and pulmonary function; as well as, being
associated with obstructive sleep apnea syndrome (OSAS),
obesity hypoventilation syndrome (OHS), and obstructive
airway disease [4–6] .S e v e r a ls t u d i e sh a v ed e m o n s t r a t e d
that weight reduction, as a result of dietary modiﬁcation
or surgical intervention, can improve organ dysfunction,
health-related quality of life (HRQoL), and overall mortality
[3, 7–9].
Bariatric surgery, with dual mechanisms of gastric vol-
ume restriction and malabsorption, has been recommended
with increasing frequency to treat patients considered mor-
bidly obese [10, 11]. Bariatric surgery aﬀords a rapid,
sustained, and safe (operative mortality at 30 or less days
was 0.1–1.1%) procedure for eﬀective weight reduction
in morbidly obese individuals [7]. Bariatric surgery may
improve the overall risk and incidence of cardiovascular
disease, diabetes, hyperlipidemia, hypertension, atheroscle-
rosis, inﬂammation, OHS, and OSAS [7, 12–14]. Bariatric
surgery has also been suggested to improve asthma control
and reduce the need for pharmacologic interventions [13–
16]. Furthermore, there is increasing evidence that bariatric
surgery is associated with a signiﬁcant improvement in
respiratory symptoms and pulmonary function [17–25].
Improvements in pulmonary function may be due to a
decrease in intra-abdominal pressure, which lends support
to the hypothesis that individuals with abdominal obesity
may be proper candidates for bariatric surgery in order to
improve pulmonary function [25].2 Journal of Obesity
Table 1: Respiratory complications of obesity.
Respiratory physiology
↓ Chest wall and lung compliance
↑ Airway resistance
↓ Respiratory muscle strength
↑ Work of breathing
↑ Ventilation perfusion mismatch
↓ Gas exchange
Pulmonary function:
↓ FEV1,F V C ,T L C ,E R V ,F R C ,a n dR V
↑→ FEV1/FVC ratio
↓ MVV
↑↓→ DLCO
FEV1: forced expiratory volume in the ﬁrst second; FVC: forced vital
capacity; TLC: total lung capacity; FRC: functional residual capacity; ERV:
expiratory reserve volume; RV: residual volume; MVV: maximal voluntary
ventilation; DLCO: diﬀusing capacity of the lung for carbon monoxide.
↑: increased; ↓: decreased; →:n oc h a n g e .
2.ObesityandPulmonary Physiology
Obesityhasaprofoundeﬀectonthephysiologyofbreathing,
including respiratory mechanics, airway resistance, respi-
ratory muscle function, lung volume, work of breathing
(WOB), and gas exchange [5]. A summary of complications
associated with obesity is presented in Table 1. Patients
classiﬁed as morbidly obese typically present with increased
metabolic demands due to the additional work required for
activities of daily living and to overcome the increased WOB.
Elevated WOB is a result of reduced chest wall compliance,
commonly associated with the accumulation of fat in and
around the chest wall, the diaphragm, and the abdomen [6].
Obesity may also cause a reduction in lung volume, periph-
eral airway diameter, and alterations in pulmonary blood
volume, which may result in a reduction in lung compliance.
Reduced respiratory compliance has been shown to result in
anincreasedoxygencostofbreathing;aswellas,anincreased
respiratory drive, both of which may increase dyspnea [21,
26]. Numerous publications have demonstrated an associa-
tion between obesity and obstructive lung disease, especially
asthma. An epidemiological connection between obesity and
obstructivelungdiseasehasbeendescribed—ameta-analysis
has shown that obesity is associated with the incidence of
asthma, independent of gender [27]. Airway inﬂammation,
narrowing of the peripheral airways, increased respiratory
resistance, and extrapulmonary trigger/aggravating factors,
such as gastroesophageal reﬂux or sleep disordered breathing
(SDB), have been proposed as explanations for the increased
incidence of obstructive pulmonary disease in obese patients
[6].
Body mass index (BMI) can be used to rapidly classify
individuals as obese. However, there is increasing evidence
that a central pattern of fat distribution (central or abdomi-
nal obesity), indicated by a larger waist circumference (WC),
waist-to-hip ratio (WHR), or waist-to-height ratio (WHtR),
h a sp r o f o u n d l ym o r en e g a t i v ee ﬀects on the respiratory
system than other anthropometric measurements of obesity
[28–33]. It has been suggested that abdominal obesity
can cause an increase in abdominal and diaphragmatic
pressure, altered pleural pressure, and a subsequent decrease
in total lung capacity, pulmonary compliance, and pul-
monary volume [34]. Sugerman et al. reported a correlation
between increased abdominal pressure and WC or sagittal
abdominal diameter (r = 0.74, 0.78), which was primarily
responsible for obesity hypoventilation due to elevation of
the diaphragm [35]. Lambert et al. also showed that intra-
abdominal pressure correlated to the sagittal abdominal
diameter, an index of the degree of central obesity, but not
body weight or BMI [36].
3. Obesity andPulmonary Function
A longitudinal study suggested that a restrictive pattern
assessed with a single spirometric test was associated with
increased morbidity and mortality [37]. It has been widely
reported that obesity can lead to restrictive pulmonary func-
tion.Thisisevidencedbyreductionsinforcedexpiratoryvol-
ume in the ﬁrst second (FEV1), forced vital capacity (FVC),
expiratory reserve volume (ERV), residual volume (RV), and
t o t a ll u n gc a p a c i t y( T L C )[ 5, 6, 29, 31, 38–40]. However, the
FEV1/FVC ratio was preserved or increased in these studies.
In addition, several studies have shown that excess weight or
simpleweightgainisassociatedwithpulmonarydysfunction
[41–44]. Chen and colleagues analyzed pulmonary function
in 1202 healthy adults in a 6-year follow-up study and
reported a decline in both FVC and FEV1 after simple weight
gain in both men and women. The eﬀect of weight gain
on pulmonary dysfunction has been shown to be greater in
men than in women. Using a multiple regression analysis,
each kilogram of weight gain was associated with reduced
FVC (−26mL) and FEV1 (−23mL) in men, and −14mL
and −9mL in women, respectively [44]. The impaired
pulmonary function may result from air-ﬂow limitations,
due to a reduction in the peripheral airway, and an increased
abdominal load that alters chest wall mechanics [35, 43,
45]. The increased abdominal pressure may play a greater
role in impaired pulmonary function and was suggested to
be responsible for the elevation of the diaphragm, thereby
producing a restrictive, rather than obstructive, pulmonary
dysfunction [35]. An increasing number of studies have also
supported the hypothesis that abdominal fat deposition is
predictive of impairments in pulmonary function, more-
so than BMI [29–32]. Ochs-Balcom et al. conducted a
population-basedstudythatassessedtheassociationbetween
pulmonary function and markers of adiposity and body fat
distribution, including body weight, BMI, WC, WHR, and
abdominal height. Their results suggested that abdominal
adiposity (WC, abdominal height) is a better predictor of
pulmonary dysfunction than weight or BMI [29]. Additional
studies in diﬀerent ethnic populations from Canada, the
United Kingdom, and Taiwan have also demonstrated that
WC is signiﬁcantly associated with decreased FEV1 and FVC
[28, 40, 46].
Maximum voluntary ventilation, a reﬂection of respi-
ratory muscle endurance and lung mechanics, has beenJournal of Obesity 3
T
a
b
l
e
2
:
P
u
l
m
o
n
a
r
y
f
u
n
c
t
i
o
n
a
f
t
e
r
b
a
r
i
a
t
r
i
c
s
u
r
g
e
r
y
—
a
r
e
v
i
e
w
o
f
p
r
i
n
c
i
p
a
l
s
t
u
d
i
e
s
.
A
u
t
h
o
r
s
Y
e
a
r
r
e
p
o
r
t
e
d
C
o
u
n
t
r
y
C
a
s
e
n
o
.
P
o
s
t
s
u
r
g
e
r
y
a
s
s
e
s
s
m
e
n
t
W
e
i
g
h
t
l
o
s
s
(
k
g
/
m
2
)
F
E
V
1
(
%
p
r
e
d
i
c
t
e
d
)
F
V
C
(
%
p
r
e
d
i
c
t
e
d
)
P
v
a
l
u
e
B
e
f
o
r
e
A
f
t
e
r
B
e
f
o
r
e
A
f
t
e
r
B
e
f
o
r
e
A
f
t
e
r
W
e
i
n
e
r
e
t
a
l
.
[
1
9
]
1
9
9
8
I
s
r
a
e
l
2
1
6
-
m
o
n
t
h
4
1
.
4
±
1
.
3
3
1
.
7
7
±
1
.
1
8
3
.
2
±
4
.
8
8
6
.
3
±
4
.
5
7
5
.
6
±
3
.
2
8
4
.
6
±
4
.
3
<
0
.
0
5
D
´
a
v
i
l
a
-
C
e
r
v
a
n
t
e
s
e
t
a
l
.
[
2
0
]
2
0
0
4
M
e
x
i
c
o
3
0
1
-
y
e
a
r
4
4
.
0
±
4
.
0
3
2
.
0
±
4
.
0
8
9
(
5
4
–
1
1
7
)
1
0
3
(
8
5
–
1
3
1
)
8
4
(
5
3
–
1
1
6
)
9
7
.
5
(
8
4
–
1
2
3
)
<
0
.
0
1
S
a
n
t
a
n
a
e
t
a
l
.
[
2
2
]
2
0
0
6
B
r
a
z
i
l
3
9
1
-
y
e
a
r
5
2
.
5
±
1
0
.
5
3
5
.
8
±
9
.
1
%
∗
∗
9
2
.
5
±
1
7
1
0
4
.
4
±
1
3
9
3
.
1
±
1
4
.
9
1
0
5
.
4
±
1
3
.
1
<
0
.
0
5
M
a
r
t
´
ı
-
V
a
l
e
r
i
e
t
a
l
.
[
2
3
]
2
0
0
7
S
p
a
i
n
3
0
1
-
y
e
a
r
5
6
.
5
±
8
.
4
3
2
.
1
±
5
.
9
7
7
.
6
±
1
4
.
4
1
0
4
.
2
±
2
9
.
5
8
2
.
0
±
1
2
.
7
1
1
4
.
6
±
1
5
.
4
<
0
.
0
1
M
a
n
i
s
c
a
l
c
o
e
t
a
l
.
[
1
6
]
2
0
0
8
I
t
a
l
y
2
2
1
-
y
e
a
r
4
5
.
2
±
4
.
7
3
4
.
8
±
4
.
2
8
3
.
0
±
1
4
.
4
8
7
.
2
±
1
4
.
9
8
7
.
8
±
1
3
.
5
9
5
.
2
±
1
0
.
7
<
0
.
0
5
N
g
u
y
e
n
e
t
a
l
.
[
2
4
]
2
0
0
9
U
S
A
1
0
4
1
-
y
e
a
r
4
8
±
6
5
4
±
2
3
%
∗
∗
1
0
0
(
b
a
s
e
l
i
n
e
)
1
1
2
±
1
6
%
1
0
0
(
b
a
s
e
l
i
n
e
)
1
0
9
±
1
6
%
<
0
.
0
1
W
e
i
e
t
a
l
.
[
2
5
]
2
0
1
1
T
a
i
w
a
n
9
4
3
-
m
o
n
t
h
4
3
.
4
±
7
.
3
3
5
.
8
±
6
.
5
9
1
.
8
±
1
5
.
3
9
7
.
7
±
1
3
.
7
9
2
.
8
±
1
5
.
0
9
7
.
6
±
1
3
.
4
<
0
.
0
1
∗
D
a
t
a
a
r
e
p
r
e
s
e
n
t
e
d
a
s
m
e
a
n
±
S
D
o
r
m
e
d
i
a
n
(
r
a
n
g
e
)
.
∗
∗
W
e
i
g
h
t
l
o
s
s
o
f
m
e
a
n
±
S
D
%
o
f
t
h
e
i
n
i
t
i
a
l
w
e
i
g
h
t
.
F
E
V
1
:
f
o
r
c
e
d
e
x
p
i
r
a
t
o
r
y
v
o
l
u
m
e
i
n
t
h
e
ﬁ
r
s
t
s
e
c
o
n
d
;
F
V
C
:
f
o
r
c
e
d
v
i
t
a
l
c
a
p
a
c
i
t
y
.4 Journal of Obesity
shown to decrease as BMI increases [47, 48]. The reduc-
tion in endurance may be related to increased peripheral
airway resistance, reduced chest wall compliance and muscle
strength, or breathing at low lung volumes [19, 48]. The
eﬀect of obesity on gas exchange, which is commonly
assessed by diﬀusion capacity of the lung for carbon monox-
ide (DLCO), is heterogeneous, and the exact pathophysi-
ological mechanism leading to changes in DLCO remains
unclear. Patients classiﬁed as obese who present with no
clinically apparent heart disease may have a high output state
and elevated total- and central-blood volumes, which will
increasecapillarybloodvolume,andtherebycauseelevations
in DLCO [38]. Reduced DLCO has also been observed in
obese individuals, which may be due to structural changes
in the interstitium of the lung as a result of lipid deposition,
alveolar enlargement, cellular hyperplasia, and/or decreased
alveolar surface area [5, 49].
Sekhri et al. examined the inﬂuence of gender and age
on pulmonary function in morbidly obese patients [39]—
results showed that being male was associated with a greater
negative impact on pulmonary function, and subjects aged
greater than 40 years had signiﬁcantly lower FVC and
FEV1/FVCthanthoseagedlessthan40years.Thediﬀerential
distribution of body fat in men and women, and the direct
correlation between abdominal obesity and increasing age
may explain Sekhri’s results [50, 51].
4. Effect of Bariatric Surgery on
Pulmonary Function
The use of surgical procedures for weight-loss when treating
morbidly obese individuals has increased dramatically since
1998, especially after the introduction of video laparo-
scopic techniques (Table 2). Bariatric surgery for individuals
considered severely obese has been shown to be associ-
ated with decreased comorbidities, reversed the respiratory
complications associated with obesity, and reduced all-
cause mortality [9]. Several studies conducted in the 1980s
reported that weight loss following gastric bypass surgery
decreased abdominal pressure and sagittal abdominal diam-
eter resulting in a reduction in pulmonary function and
respiratory comorbidities, such as SDB, OHS, and OSAS
[17, 52]. Increasing evidence has been become available that
emphasizes improved pulmonary function after bariatric
surgery [16–24]. Sugerman et al. demonstrated signiﬁcantly
improved lung volumes in 26 patients with OHS after gastric
bypass surgery [17]. Thomas et al. reported similar results
following weight loss surgery—in 29 patients, a small but
signiﬁcant rise in FVC (7%; P = 0.002) and FEV1 (6%; P =
0.017) after a mean weight loss of 34.2kg (range: 2–64kg)
[18]. Weiner et al. has reported signiﬁcant increases in FVC
in 21 morbidly obese patients following weight loss surgery,
withno signiﬁcant change in FEV1 and FEV1/FVCratio [19].
D´ avila-Cervantes et al. described 30 morbidly obese patients
with improved FEV1 (89% to 103%) and FVC (84% to
97.5%) one year after vertical banded gastroplasty [20]. Sim-
ilarly, Mart´ ı-Valeri etal.examined 30patients withimproved
FEV1 (78% to 104%) and FVC (82% to 115%) one year after
gastricbypasssurgery[23].Maniscalcoetal.alsoreportedan
improvement in FEV1 (83% to 87%) and FVC (88% to 95%)
in 12 obese females with asthma one year after gastric bypass
surgery[16].InastudyconductedbySantanaetal.,FVCand
FEV1 were signiﬁcantly improved in 39 patients following
weight-loss surgery. Pulmonary function was improved to
a greater extent in patients considered severely morbidly
obese (BMI ≥ 60kg/m2) compared with less morbidly obese
patients (BMI: 40–59.9kg/m2)[ 22]. Nguyen et al. examined
pulmonary function in 104 morbidly obese patients who
underwent either laparoscopic gastric bypass or gastric
banding. Restrictive and obstructive respiratory mechanics
associated with obesity were signiﬁcantly improved after
surgically induced weight loss and were observed as early as
three months after surgery [24] .Ar e c e n ts t u d yc o n d u c t e d
by Wei et al. showed that each kilogram of body weight lost
aftersurgery was associated with an improvement of 0.28%
(9.4mL) in FEV1 and 0.23% (9.1mL) in FVC. In addition,
reduced WC was associated with a reversal of impaired
pulmonaryfunction—witheachcentimeterofWCreduction
FEV1 and FVC increased by 0.44% (14.8mL) and 0.36%
(14.3mL), respectively [25]. In a previous study reported by
Zavorskyetal.,DLCOwasfoundtoimprovewithin10weeks
of bariatric surgery and was strongly associated with changes
in alveolar volume and WHR, an indicator of central obesity
[53]. Lastly, a study reported by Oppenheimer et al. showed
signiﬁcant distal airway dysfunction, as detected by impulse
oscillometry, in obese subjects despite normal spirometric
ﬁndings. These abnormalities were signiﬁcantly improved
after bariatric surgery [54].
5. Summary
Therapeutic interventions need balance eﬃcacy against risk.
Bariatric surgery is a rapid, sustained, and safe surgical
procedure for eﬀective weight reduction in morbidly obese
individuals. Overall, eﬀective weight loss by bariatric surgery
has been demonstrated to be associated with improved
pulmonary function. Individuals with larger WC may be
candidates for bariatric surgery in an eﬀort to reverse im-
paired pulmonary function. Identiﬁcation of patients who
will beneﬁt the most from bariatric surgery to improve
other symptoms and clinical associations, such as dyspnea,
asthma, OHS, or OSAS, is warranted and requires future
investigation.
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